International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 144662 - 144662
Published: May 1, 2025
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 144662 - 144662
Published: May 1, 2025
Language: Английский
Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 12
Published: Feb. 11, 2025
Currently, CAR-T cell therapy is known as an efficacious treatment for patients with relapsed/refractory hematologic malignancies. Nonetheless, this method faces several bottlenecks, including low efficacy solid tumors, lethal adverse effects, high cost of autologous products, and the risk GvHD in allogeneic settings. As a potential alternative, CAR-NK can overcome most limitations provide off-the-shelf, safer, more affordable product. Although published results from preclinical clinical studies cells are promising, bottlenecks must be unlocked to maximize effectiveness therapy. These include vivo persistence, trafficking into tumor sites, modest sensitivity immunosuppressive microenvironment. In recent years, advances gene manipulation tools strategies have laid groundwork current This review will introduce existing discuss their advantages disadvantages. We also explore how these enhance therapy’s safety efficacy.
Language: Английский
Citations
3Neoplasia, Journal Year: 2025, Volume and Issue: 62, P. 101147 - 101147
Published: March 3, 2025
Language: Английский
Citations
1International Immunopharmacology, Journal Year: 2025, Volume and Issue: 151, P. 114261 - 114261
Published: Feb. 26, 2025
Language: Английский
Citations
0Cancer Letters, Journal Year: 2025, Volume and Issue: unknown, P. 217792 - 217792
Published: May 1, 2025
Language: Английский
Citations
0Journal of Translational Medicine, Journal Year: 2025, Volume and Issue: 23(1)
Published: May 23, 2025
The dysfunction of wound-healing processes can result in chronic non-healing wounds and pathological scar formation. Current treatment options often fall short, necessitating innovative approaches. Exosomes, extracellular vesicles secreted by various cells, have emerged as promising therapeutic agents serving an intercellular communication system. By engineering exosomes, their cargo surface properties be tailored to enhance efficacy specificity. Engineered exosomes (eExo) are emerging a favorable tool for treating scars. In this review, we delve into the underlying mechanisms scars, outline current state strategies, explore clinical potential eExo based on preclinical studies. addition, address challenges future research directions, including standardization, safety assessments, immune responses. conclusion, hold great promise novel approach Further trials warranted translate findings effective treatments.
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 144662 - 144662
Published: May 1, 2025
Language: Английский
Citations
0